381 related articles for article (PubMed ID: 16935698)
1. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
2. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
Azadbakht L; Shakerhosseini R; Atabak S; Jamshidian M; Mehrabi Y; Esmaill-Zadeh A
Eur J Clin Nutr; 2003 Oct; 57(10):1292-4. PubMed ID: 14506491
[TBL] [Abstract][Full Text] [Related]
3. Serum and erythrocyte membrane phospholipids fatty acid composition in hyperlipidemia: effects of dietary intervention and combined diet and fibrate therapy.
Ristic-Medic D; Suzic S; Vucic V; Takic M; Tepsic J; Glibetic M
Gen Physiol Biophys; 2009; 28 Spec No():190-9. PubMed ID: 19893100
[TBL] [Abstract][Full Text] [Related]
4. [Effects of the relative enrichment of polyunsaturated fatty acids in insulin-dependent diabetic patients].
De Leeuw IH; Van Gaal L; Rillaerts E; Dalemans C
Diabete Metab; 1986 Oct; 12(5):246-9. PubMed ID: 3803678
[TBL] [Abstract][Full Text] [Related]
5. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
[TBL] [Abstract][Full Text] [Related]
6. [Relations of platelet phospholipid fatty acids to thrombotic risk factors in middle-aged and geriatric patients with hyperlipidemia].
Yu XM; Li D; Xie HB; Zhang YH; Wang Q; Zhou XQ; Yu P; Wang LJ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):105-8. PubMed ID: 17418017
[TBL] [Abstract][Full Text] [Related]
7. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
[TBL] [Abstract][Full Text] [Related]
8. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
9. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
[TBL] [Abstract][Full Text] [Related]
10. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
[TBL] [Abstract][Full Text] [Related]
11. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
12. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[TBL] [Abstract][Full Text] [Related]
13. Effects of different quantities of fat on serum and liver lipids, phospholipid class distribution and fatty acid composition in alcohol-treated rats.
Ristić-Medić D; Ristić G; Tepsić V; Ristić GN
J Nutr Sci Vitaminol (Tokyo); 2003 Dec; 49(6):367-74. PubMed ID: 14974725
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults.
Liao FH; Shieh MJ; Yang SC; Lin SH; Chien YW
Nutrition; 2007; 23(7-8):551-6. PubMed ID: 17574819
[TBL] [Abstract][Full Text] [Related]
15. Effect of raloxifene on serum lipids for type 2 diabetic menopausal women with or without statin treatment.
Matsumura M; Monden T; Nakatani Y; Shimizu H; Domeki N; Yanagi K; Ikeda S; Kawagoe Y; Kasai K
Med Princ Pract; 2010; 19(1):68-72. PubMed ID: 19996623
[TBL] [Abstract][Full Text] [Related]
16. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
17. Monounsaturated fatty acid (avocado) rich diet for mild hypercholesterolemia.
López Ledesma R; Frati Munari AC; Hernández Domínguez BC; Cervantes Montalvo S; Hernández Luna MH; Juárez C; Morán Lira S
Arch Med Res; 1996; 27(4):519-23. PubMed ID: 8987188
[TBL] [Abstract][Full Text] [Related]
18. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
19. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus.
Ashraf R; Aamir K; Shaikh AR; Ahmed T
J Ayub Med Coll Abbottabad; 2005; 17(3):60-4. PubMed ID: 16320801
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
